Veracity Capital’s Merck MRK Stock Holding History

Veracity Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,000	Closed	-$150K	–	270
2021 Q3	$150K	Hold	2,000	–	–	0.06%	232
2021 Q2	$155K	Sell	2,000 -2,192	-52%	-$163K	0.04%	240
2021 Q1	$310K	Buy	+4,192	New	+$309K	0.07%	218

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Veracity Capital's MRK Position: Q3 2025 in Review

Veracity Capital sold out of Merck (MRK) in Q3 2025, closing a stake of 2,568 shares — an estimated $203K sold.

Veracity Capital first reported a position in MRK in Q4 2019 and held it in 22 quarters. The position peaked at $1.86M in Q2 2023. 3,310 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

Veracity Capital reported no remaining Merck position as of Q3 2025 after selling out during the quarter.
Veracity Capital sold 2,568 Merck shares in Q3 2025, an estimated $203K.
Veracity Capital first reported a position in Merck in Q4 2019 and held it in 22 quarters.
Veracity Capital's Merck position peaked at $1.86M in Q2 2023.
3,310 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on Veracity Capital's 13F filing for Q3 2025, filed 8 Oct 2025.